177 related articles for article (PubMed ID: 26013698)
1. Significance of monocyte counts on tumor characteristics and survival outcome of women with endometrial cancer.
Matsuo K; Hom MS; Moeini A; Machida H; Takeshima N; Roman LD; Sood AK
Gynecol Oncol; 2015 Aug; 138(2):332-8. PubMed ID: 26013698
[TBL] [Abstract][Full Text] [Related]
2. Significance of Monocyte Counts at Recurrence on Survival Outcome of Women With Endometrial Cancer.
Machida H; De Zoysa MY; Takiuchi T; Hom MS; Tierney KE; Matsuo K
Int J Gynecol Cancer; 2017 Feb; 27(2):302-310. PubMed ID: 27922978
[TBL] [Abstract][Full Text] [Related]
3. Preoperative Circulating Lymphocyte and Monocyte Counts Correlate with Patient Outcomes in Type I and Type II Endometrial Cancer.
Burgess B; Levine B; Taylor RN; Kelly MG
Reprod Sci; 2020 Jan; 27(1):194-203. PubMed ID: 32046381
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of pre-operative neutrophil/lymphocyte ratio, monocyte count, mean platelet volume, and platelet/lymphocyte ratio in endometrial cancer.
Temur I; Kucukgoz Gulec U; Paydas S; Guzel AB; Sucu M; Vardar MA
Eur J Obstet Gynecol Reprod Biol; 2018 Jul; 226():25-29. PubMed ID: 29804024
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Monocyte Count as a Mirror of Tumor Characteristics and Likelihood of Recurrence in Endometrial Carcinoma Cases.
Modares Gilani M; Kazemi Z; Zamani N; Shahrami H; Ghahghaei-Nezamabadi A; Sheikham S
Asian Pac J Cancer Prev; 2018 Apr; 19(4):897-899. PubMed ID: 29693335
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of systemic neutrophil and leukocyte alterations in surgically treated endometrial cancer patients: a monoinstitutional study.
Takahashi R; Mabuchi S; Kawano M; Sasano T; Matsumoto Y; Kuroda H; Hisamatsu T; Kozasa K; Sawada K; Hamasaki T; Kimura T
Gynecol Oncol; 2015 Apr; 137(1):112-8. PubMed ID: 25680864
[TBL] [Abstract][Full Text] [Related]
7. The Significance of Pretreatment Thrombocytosis and Its Association With Neutrophilia in Patients With Surgically Treated Endometrial Cancer.
Takahashi R; Mabuchi S; Kuroda H; Kozasa K; Yokoi E; Matsumoto Y; Kimura T
Int J Gynecol Cancer; 2017 Sep; 27(7):1399-1407. PubMed ID: 28604454
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of women with apparent stage I endometrial cancer who had supracervical hysterectomy.
Matsuo K; Machida H; Takiuchi T; Garcia-Sayre J; Yessaian AA; Roman LD
Gynecol Oncol; 2017 Apr; 145(1):41-49. PubMed ID: 28215841
[TBL] [Abstract][Full Text] [Related]
9. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer.
Mell LK; Meyer JJ; Tretiakova M; Khramtsov A; Gong C; Yamada SD; Montag AG; Mundt AJ
Clin Cancer Res; 2004 Aug; 10(16):5546-53. PubMed ID: 15328195
[TBL] [Abstract][Full Text] [Related]
11. Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer.
Matsuo K; Cahoon SS; Gualtieri M; Scannell CA; Jung CE; Takano T; Paulson RJ; Muderspach LI; Roman LD
Ann Surg Oncol; 2014 Dec; 21(13):4246-55. PubMed ID: 25001096
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of preoperative monocyte counts in patients with resected lung adenocarcinoma.
Kumagai S; Marumo S; Shoji T; Sakuramoto M; Hirai T; Nishimura T; Arima N; Fukui M; Huang CL
Lung Cancer; 2014 Sep; 85(3):457-64. PubMed ID: 25043641
[TBL] [Abstract][Full Text] [Related]
13. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
[TBL] [Abstract][Full Text] [Related]
14. Endometrial cancer arising in adenomyosis versus endometrial cancer coexisting with adenomyosis: are these two different entities?
Machida H; Maeda M; Cahoon SS; Scannell CA; Garcia-Sayre J; Roman LD; Matsuo K
Arch Gynecol Obstet; 2017 Jun; 295(6):1459-1468. PubMed ID: 28444512
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
Zhu J; Wen H; Bi R; Wu X
J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
[TBL] [Abstract][Full Text] [Related]
16. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
17. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of lymphovascular space invasion in low-risk endometrial cancer.
Ayhan A; Şahin H; Sari ME; Yalçin I; Haberal A; Meydanli MM
Int J Gynecol Cancer; 2019 Mar; 29(3):505-512. PubMed ID: 30665899
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of preoperative plasma fibrinogen in endometrial cancer.
Ghezzi F; Cromi A; Siesto G; Giudici S; Serati M; Formenti G; Franchi M
Gynecol Oncol; 2010 Nov; 119(2):309-13. PubMed ID: 20688365
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological factors predicting retroperitoneal lymph node metastasis and survival in endometrial cancer.
Tang X; Tanemura K; Ye W; Ohmi K; Tsunematsu R; Yamada T; Katsumata N; Sonoda T
Jpn J Clin Oncol; 1998 Nov; 28(11):673-8. PubMed ID: 9861234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
